Liver lipid content is reduced in rat given 7-day administration of angiotensin II. (Q50528484)

14 March 2018

title

Liver lipid content is reduced in rat given 7-day administration of angiotensin II. (English)

1 reference

14 March 2018

6

Kazuhiko Koike

1 reference

14 March 2018

author name string

Nobukazu Ishizaka

1

1 reference

14 March 2018

Makiko Hongo

2

1 reference

14 March 2018

Aiko Sakamoto

3

1 reference

14 March 2018

Kan Saito

4

1 reference

14 March 2018

Kyoko Furuta

5

1 reference

14 March 2018

publication date

2 August 2011

1 reference

14 March 2018

Journal of the Renin-Angiotensin-Aldosterone System

published in

1 reference

14 March 2018

volume

12

1 reference

14 March 2018

issue

4

1 reference

14 March 2018

page(s)

462-468

1 reference

14 March 2018

Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Impact of inhibitors of the Renin-Angiotensin-aldosterone system on liver fibrosis and portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Administration of ANG II induces iron deposition and upregulation of TGF-beta1 mRNA in the rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Lipid accumulation and transforming growth factor-beta upregulation in the kidneys of rats administered angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Administration of angiotensin II, but not catecholamines, induces accumulation of lipids in the rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats : possible role in renoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Cardiac overexpression of hormone-sensitive lipase inhibits myocardial steatosis and fibrosis in streptozotocin diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Effects of the AT(1) receptor blocker losartan and the calcium channel blocker benidipine on the accumulation of lipids in the kidney of a rat model of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Evidence for a major role of skeletal muscle lipolysis in the regulation of lipid oxidation during caloric restriction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Sympathetic modulation by carvedilol and losartan reduces angiotensin II-mediated lipolysis in subcutaneous and visceral fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Adrenergic regulation of lipolysis in abdominal adipocytes of obese subjects during caloric restriction: reversal of catecholamine action caused by relief of endogenous inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Angiotensin II stimulates transcription of insulin-like growth factor I receptor in vascular smooth muscle cells: role of nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Chronic ANG II infusion increases plasma triglyceride level by stimulating hepatic triglyceride production in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Angiotensin II infusion increases hepatic triglyceride production via its type 2 receptor in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Oxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

ANG II type I receptor antagonism improved nitric oxide production and enhanced eNOS and PKB/Akt expression in hearts from a rat model of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320311415887

21 January 2018

Identifiers

DOI

10.1177/1470320311415887

1 reference

14 March 2018

PubMed ID

21810895

1 reference

14 March 2018